GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Frequency and phenotypic spectrum of spinocerebellar ataxia <scp>27B</scp> and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia2023 · 41 citations
2. 2Ataxia and Paroxysmal Dyskinesia in Mice Lacking Axonally Transported FGF142002 · 187 citations
3. 3Deep Intronic <i>FGF14</i> GAA Repeat Expansion in Late-Onset Cerebellar Ataxia2022 · 248 citations
4. 4Clinical and genetic keys to cerebellar ataxia due to FGF14 GAA expansions2023 · 58 citations
5. 5A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms2013 · 100 citations